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Abstract 
Background: Left ventricular hypertrophy (LVH) is an independent risk factor for adverse cardiac outcomes in 
hypertensive patients. 
Objective: This study is designed to assess the cardiovascular responses to treadmill exercise among Nigerian 
hypertensives with echocardiographically proven LVH.
Materials and Methods: Fifty hypertensive patients with LVH (27 males and 23 females) between 30 and 65 years 
of age were studied in Nigeria. 50 hypertensive patients without LVH and 50 normal subjects who were age and sex 
matched served as controls. All patients and control subjects underwent M-mode, 2-D and Doppler ECHO-studies and 
the Bruce protocol treadmill exercise test. 
Results: The study showed that the estimated maximal oxygen consumption (MVO2) in MET reduced progressively 
from 8.39 ± 1.26 (normotensive control) to 7.62 ± 1.33 (hypertensive without LVH), 6.27 ± 0.99 (hypertensive with 
LVH) (P<0.0001ANOVA). The duration of exercise (s) was also reduced in that order from 455.4 ± 79.1 to 411.6 ±8 
2.3, 315.8 ± 75.6 respectively (P<0.0001). The systolic blood pressure (SBP) and pressure rate product (PRP) during 
maximal exercise were also increased in hypertensives with LVH and hypertensive without LVH when compared to 
normotensive controls. The hypertensives with LVH and hypertensives without LVH also showed significant limitation 
to heart rate increase with exercise compared to normotensive controls (P<0.003). 
Conclusion: This study demonstrated significant impairment of exercise capacity in hypertensives with or without LVH 
compared to normotensive subjects. Both earlier recognition and improved understanding of LVH may lead to more 
effective therapeutic strategies for this cardiovascular risk factor. 
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Left ventricular hypertrophy (LVH) has been shown to be 
a significant risk factor for adverse cardiac outcome both in 
the general population and in patients with hypertension, 
even without underlying heart disease.[1-3]
LVH was initially thought to be a beneficial compensatory 
mechanism for maintaining normal wall stress in LV 
pressure and volume overload, epidemiological studies using 
electrocardiography (ECG) and recently echocardiography 
(ECHO) have elucidated the profound independent risk of 
LVH for congestive heart failure (CHF), coronary events, 
life threatening arrhythmias and cardiac mortality.
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Exercise testing has become standardized for the diagnostic 
and functional evaluation of patients with cardiovascular 
disease.
Some studies have shown that impaired exercise performance 
in Nigerian hypertensives occur with onset of LVH.[4-6]
Systolic BP at the end of maximal exercise has been more 
closely correlated than resting systolic blood pressure 
with LV mass.[7] It is also possible that the exaggerated 
BP response to exercise in normotensives with parental 
hypertension reflects the presence of LVH.
It has been suggested that the volta ge LVH on the ECG 
may be an early marker of impaired exercise capacity.[8]
While impaired exercise capacity has been demonstrated 
in Nigerian hypertensive patients with ECG-LVH and/or 
cardiomegaly on chest X-ray there is a paucity of data relating 
ECHO LVH and diastolic function to exercise capacity.
The purpose of this study therefore is to evaluate the 
association of LVH and dysfunction with abnormal exercise 
capacity among Nigerian hypertensives.
Materials and Methods
50 hypertensive patients with ECHO proven LVH attending 
the cardiology unit of OAUTHC, Ile-Ife who are between 
the ages of 30 – 65 years were studied after informed consent 
and ethical clearance have been obtained.
50 hypertensive patients without ECHO proven LVH and 
50 normal subjects who were age and sex matched served 
as control groups. The control subjects were volunteers 
recruited from among hospital staff, medical and nursing 
students, and members of the local community.
For this study, the exclusion criteria for participants included 
the following: – 
•	 Patients with diabetes mellitus 
•	 Patients with chronic kidney disease with serum 
creatinine <176µmol/l in the last 3 months and free of 
structural kidney damage.[9,10]
•	 Patients with Chronic Obstructive Airway Disease
•	 Use of β - blockers or digoxin, atrial fibrillation, bundle 
branch block, and baseline ST – segment abnormalities.
•	 Patients with congestive heart failure and valvular heart 
disease.
•	 Severely obese patients.
•	 Patients with severe arthritic pains and other exercise 
limiting musculoskeletal diseases.
Procedure
All patients were examined clinically to evaluate their 
body mass index and cardiovascular status at rest and 
identify individuals with contraindications to exercise 
testing. Subjects were considered to be hypertensive 
if they had a resting SBP of >140mmHg or a resting 
DBP of >90mmHg or if they were on antihypertensive 
medication, excluding drugs such as methyl dopa and 
dihydropyridine calcium channel blockers which could 
influence heart rate.
All patients and control subjects underwent Chest X-ray, 
12-lead ECG, M-mode, 2-D and Doppler ECHO-studies 
and the Bruce protocol treadmill exercise test. Complete 
blood count, serum chemistry screening and blood sugar 
were also performed
Echocardiographic study
Echocardiography was performed with a Sonoline G60 S 
ultrasound system with 4.2-6.2 MHz transducer.
Images of the heart were obtained in multiple cross-sectional 
planes with the use of standard transducer position with the 
subject in the left lateral decubitus position.
Measurements were in accordance with the recommendations 
of the American Society of Echocardiography.[11]    
Except for LV systolic dimension (LVSD) that was taken at 
end systole, other wall thickness and cavity measurements, 
were done at end diastole. End systole was recognized as 
the nadir of the septal motion and/or the peak of the LV 
posterior wall motion.
In each subject, three (3) consecutive cardiac cycles were 
obtained for analysis.
Doppler echocardiography
Each subject was examined in the left lateral decubitus 
position with the transducer at or slightly to the left of the 
apical impulse to obtain apical four-chamber view of the 
heart, to visualize the LV cavity and obtain the maximal 
excursion of the mitral valve leaflets.
When the transducer is slightly angulated anteriorly from 
the standard 4-chamber plane, a 5-chamber view was 
obtained which included the aortic valve, aortic root and 
the LV outflow tract. The Doppler mode was then selected 
on the scanner machine and simultaneously 2D and pulsed 
Doppler examination were performed. The sample volume 
was placed to determine the left and right ventricular inflow 
and outflow. The Doppler sample volume was positioned in 
the inflow area of the LV (and RV) between the tips of the 
mitral (and tricuspid) valves leaflets, as they open during 
diastole. The area was interrogated to obtain wave forms 
with the highest peaks of diastolic flow velocity and the 
optimal signal to noise ratio: these are usually identified 
within the LV cavity about 1cm below the mitral annulus 
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near the tips of the mitral leaflets. Tracing of at least three 
cardiac cycles were analyzed and averaged.
LV Diastolic function
The following Doppler indices of LV diastolic filling were 
obtained.[12,13]
•	 Peak early transmitral filling velocity (E)
•	 Peak late transmitral filling velocity (A)
•	 The ratio of early and late transmitral filling velocities 
(E/A)
•	 Deceleration time of the early transmitral filling velocity 
(Dct; time of peak early transmitral velocity to baseline).
•	 Isovolumic relaxation time (IVRT). 
In each subject 3 consecutive cardiac cycles were chosen 
for analysis.
LV systolic function 
The following measurements were used to assess the LV 
systolic function.








LV mass (LVM) was estimated according to the American 
Society of Echocardiography convention (ASE)[14] whereby:- 
LVM = 0.80 (1.04 (LVIDD + PWT + IVST)3 – (LVIDD)3) 
+ 0.6g.
Where IVST = Interventricular Septal wall thickness 
LVPWT = LV posterior wall thickness.
LV mass index was derived by dividing LVM by body height.
LVM Index = LVM/Height.
LVH was defined as a LV mass index greater than 143g/m 
for men and 102g/m for women[15]
Exercise testing 
A standard multistage maximal exercise test was conducted 
on a motorized treadmill (Schiller MTM 1500) according to 
Bruce protocol.[16] The exercise testing began with subjects 
walking slowly for 3 min at 1.7m/h at a 10% grade; speed 
and grade then increased every 3 min until exhaustion.
Each subject was instructed to exercise to his maximum 
performance but was made to understand that he could 
stop voluntarily by indicating if he had any symptoms such 
as chest pain, muscle cramps, intolerable fatigue, low back 
ache, dizziness or breathlessness etc.
The electrocardiogram, heart rate and blood pressure were 
recorded during the last minute of each stage of exercise.
The electrocardiogram was continuously monitored on 
the Schiller CS-200 12 – channel electrocardiographic 
monitor. Leads II, aVF ad V5 were continuously displayed 
on the monitor throughout exercise. The subjects’ 
electrocardiogram, blood pressure and heart rate were 
monitored and recorded during the post exercise period 
every 2 min for an average of 10 min. 
The laboratory and equipment conformed to the 
specifications for exercise testing equipments[16]. The 
exercise laboratory was provided with an air-conditioner 
and room temperature maintained between 20°C and 25°C.
A defibrillator, cardio/Pak 936/S (Mennen Medical Inc, 
New York, USA) equipped with portable ECG monitor, and 
emergency care drugs were provided.
The following parameters were measured
•	 Duration of exercise (DOE) in seconds and from this 
maximal oxygen uptake was estimated 
•	 Maximal (Exercise) heart rate (MHR) in beats per 
minutes.
•	 Metabolic equivalent (MET): As an index of exercise 
capacity estimated metabolic equivalent of workload 
was calculated from the exercise time as:-
•	 MET = 1.11 + 0.016 ¥.[16]
•	 Where ¥ is the exercise time in second.
•	 Rate Pressure product (or double product) is a measure 
of myocardial oxygen uptake during clinical exercise 
testing. It is estimated by the product of heart rate and 
systolic blood pressure.
Statistical analysis 
The results were expressed as mean ± standard deviation. 
Statistical analysis was by analysis of variance and further 
comparisons were carried out by t-test. The relationship 
between variables was determined by simple and multiple 
linear regressions. Pearson correlation coefficient was used 
to determine correlation among variables. Ninety nine 
percent confidence interval was quoted where appropriate 
and null hypotheses was rejected at P<0.05.          
Data was analyzed on a Pentium M computer with an SPSS 
13.0 version statistical package.
Results
General
Hypertensives with LVH were well matched for age, sex 
and body mass index with hypertensives without LVH and 
normotensive controls [Table 1].
Serum creatinine values were significantly different, among the 
groups (P = 0.020) although they were within normal limits.
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The resting systolic and diastolic blood pressures were 
significantly higher in hypertensive with LVH than 
normotensive controls; 143.6 (± 8.2) mmHg vs 121.4 
(± 7.2) mmHg (P< 0.001) and 87.2 (± 6.4) mmHg vs 76.4 
( ± 4.8)mmHg (P< 0.001) respectively.
However, the SBP and DBP values at rest were higher 
among the hypertensives with LVH than the hypertensives 
without LVH but only the SBP 143.6 (± 8.2) mmHg vs 139.4 
(± 10.3) mmHg was statistically significant (P< 0.05).
In comparison with normotensive controls both the systolic 
and diastolic BP of hypertensives without LVH were 
significantly higher (P<0.001)
Exercise testing
Exercise duration was significantly lower in hypertensives 
with LVH compared to both the hypertensives without LVH 
and normotensive controls 315.8(±75.6) sec vs 411.6(± 82.3) 
sec (P<0.001) for hypertensives without LVH and 315.8(± 
75.6) s vs 455.4 (± 79.1) sec (P<0.001) for normotensive 
subjects. [Table 2]
The exercise duration in normal subjects was also significantly 
higher than the hypertensive without LVH group P< 0.001.
The normotensive subjects have higher metabolic equivalent 
(MET) than the hypertensive with LVH patients 8.39 
(± 1.26) mets vs 6.27(± 0.99) mets (P< 0.001).
Hypertensive without LVH patients also have significantly 
higher MET than the hypertensive with LVH patients 
7.62(± 1.33) mets vs 6.27 (± 0.99) mets (P< 0.001).
Maximal heart rate was significantly lower in hypertensives 
with LVH when compared to both the hypertensives without 
LVH and normotensive controls 175.2(± 19.4) beats/min vs 
179.9 (± 7.8) beats/min P< 0.05 for hypertensives without 
LVH and 175.2 (± 19.4) beats/min vs 184.9(± 12.6) beats/
min P< 0.05 for normotensive controls.
The SBP at maximum exercise was significantly higher 
among hypertensives with LVH when compared with 
normotensive controls 210.3(± 17.9) mmHg vs 184.2 
(± 10.2)mmHg P< 0.001.












Age (years) 46.6 ± 8.45 47.2 ± 7.7 48.3 ± 5.8 0.177 (NS)
Sex (M/F) 25/25 27/23 24/26 0.142 (NS)
BMI (kg/m2) 24.3 ± 2.0 24.5 ± 2.5 25.4 ± 1.9 0.160 (NS)
CTR 0.47 ± 0.01 0.48 ± 0.02 0.48 ± 0.03  0.160 (NS)
SBP at rest (mmHg) 121.4 ± 7.2 139.4 ± 10.3 143.6 ± 8.2 0.000 (S)
DBP at rest (mmHg) 76.4 ± 4.8 86.4 ± 5.2 87.2 ± 6.4 0.000 (S)
HR at rest (beats/min) 83.8 ± 6.6 85.5 ± 8.0 88.6 ± 9.4 0.014 (S)
Serum creatinine (um/l) 69.1 ± 29.1 96.3 ± 23.4 102.7 ± 26.5 0.020 (S)
Serum cholesterol (mmol/l) 4.63 ± 0.32 4.77 ± 0.46 4.81 ± 0.29 0.129 (NS)
S = Statistically significant; NS = Not statistically significant; CTR = Cardiothoracic ratio; BMI = Body mass index; SBP = Systolic blood pressure;  
DBP = Diastolic blood pressure; HR = Heart rate












SBP at rest (mmHg) 121.4 ± 7.2 139.4 ± 10.3 143.6 ± 8.2 0.001 (S)
SBP max (mmHg) 184.2 ± 10.2 204.6 ± 23.1 210.3 ± 17 0.001 (S)
DBP at rest (mmHg) 76.4 ± 4.8 86.4 ± 5.25 87.2 ± 6.4 0.001 (S)
DBP max (mmHg) 89.2 ± 6.9 99.4 ± 6.51 100.6 ± 7.1 0.001 (S)
HR at rest (beats/m) 83.8 ± 6.6 85.5 ± 8.0 88.6 ± 9.40 0.014 (S)
HR max (beats/m) 184.9 ± 12.6 179.9 ± 7.8 175.2 ± 19 0.003 (S)
RPP at rest (mmHg b/m) 10218 ± 1213 11918 ± 1480 12722 ± 1833 0.001 (S)
RPP max (mmHg b/m) 34058 ± 2314 36807 ± 3894 36844 ± 4706 0.001 (S)
Stage 3.5 ± 0.3 3.16 ± 0.48 2.72 ± 0.34 0.001 (S)
DOE (s) 455.4 ± 79.1 411.6 ± 82.3 315.8 ± 75.6 0.001 (S)
MET 8.39 ± 1.26 7.62 ± 1.33 6.27 ± 0.99 0.001 (S)
S = Statistically significant; SBP = Systolic blood pressure; DBP = Diastolic blood pressure; HR = Heart rate; RPP = Rate pressure product; DOE = 
Duration of exercise; MET = Metabolic equivalent
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The rate pressure product which is a measure of myocardial 
oxygen demand was significantly higher among hypertensives 
with LVH when compared with both hypertensives and 
nomotensive controls 36844(± 4706)mmHg beats/min vs 
36807(± 3894)mmHg beats/min for the hypertensive controls 
(P< 0.05) and 36844(± 4706)mmHg beats/min vs 34058(± 
2314)mmHg beats/min for the normotensives P< 0.001.
Echocardiographic parameters
There are statistically significant difference in the value of 
left ventricular mass, left ventricular mass index, and left 
ventricular diastolic and systolic dimension between the 
hypertensives with LVH , hypertensive and normotensive 
controls. [Table 3]
Hypertensives with LVH have a LV mass of 240.6 ± 50.4g 
while hypertensive controls have a LV mass of 154.5 ± 40.0g 
(P< 0.001) and normotensives have a LV mass of 152.8 ± 
37.6g (P< 0.001).
There is no statistically significant difference between the 
LV mass of hypertensives without LVH and normotensive 
controls (P = 0.82). The left ventricular diastolic dimension 
for hypertensives with LVH was 4.70 (± 0.40)cm vs 4.58 
± 0.36cm for hypertensive patients (P<0.001) and 4.19 ± 
0.54cm for normotensive controls (P<0.001).
Univariate analysis of Echocardiographic parameters 
that correlate with metabolic equivalent 
There is a significant correlation between the fractional 
shortening, ejection fraction and MET in hypertensives 
with LVH r = -0.38 and – 0.34 respectively; P = 0.006 and 
0.017 respectively. [Table 4]
There is also a significant correlation between their IVRT 
and metabolic equivalent r = -0.42 (P = 0.002).
There is a significant positive correlation between mitral 
E velocity, mitral E/A ratio and MET r = 0.39 and 0.30 
respectively; P = 0.004 and 0.03 respectively. 
Multiple regression analysis of ECHO parameters that 
correlate with Metabolic equivalent
Multivariate analysis was performed with all univariate 
variables (P < 0.05). The result showed that all these 
variables have 17% contribution to the prediction of 
metabolic equivalent. The multivariate independent 
predictors for a higher metabolic equivalent were a lower 
IVRT and lower LVMI. [Table 5]
Discussion
This study demonstrated significant impairment of exercise 
capacity in hypertensives with or without LVH compared 
to normotensive subjects. This is in keeping with previous 
studies.[4,5,17] Balogun et al.[4] studied the influence of 
hypertension on the exercise performance in normotensives, 
hypertensives and patients with hypertensive heart failure 
and found a progressive reduction of the systolic rise in 
blood pressure during exercise, exercise induced tachycardia, 
exercise time, and maximal oxygen uptake.
Since the subjects were well matched for age, sex and 
habitual physical activity, the differences observed may be 
attributable to the effect of the disease on the functional 
capacity of the patients. Maximal heart rate was significantly 
lower in hypertensives with LVH than hypertensive and 
normotensive controls. 
Reduced maximal heart rate values in hypertensives 
compared with nomotensives have been observed in 
other studies with increasing severity of hypertension[17,18]. 
Previous groups have reported abnormal chronotropic 
responses in healthy subjects with increased LV mass 
and increased LV cavity size[19]. This might be due to 
the neurohormonal abnormalities associated with left 
ventricular hypertrophy and dilatation, most especially 
reduced sympathetic reserve. The reduction in maximal 
heart rate in this study may in part contribute to the 
impairment of exercise capacity by limiting cardiac output 
and thus exercise capacity. 












LVDd ( cm) 4.19 ± 0.54 4.58 ± 0.36 4.70 ± 0.40 0.001 (S)
LVDs (cm) 2.6 ± 0.53 2.94 ± 0.41 3.04 ± 0.45 0.001 (S)
FS ( % ) 37.7 ± 6.88 37.1 ± 5.77 35.3 ± 7.5 0.194 (NS)
EF ( % ) 74.0 ± 8.6 74.3 ± 8.0 71.7 ± 10.4 0.348 (NS)
IVST ( cm ) 0.96 ± 0.14 1.11 ± 0.2 1.35 ± 0.18 0.001 (S)
PWT (cm ) 0.94 ± 0.15 1.02 ± 0.18 1.22 ± 0.16 0.001 (S)
LV Mass (g) 152.8 ± 37.6 154.5 ± 40.0 240.6 ± 50.4 0.001 (S)
LV Mass index (g/m) 91.5 ± 21.0 92.1 ± 23.1 145.8 ± 28.3 0.001 (S)
S = Statistically significant; NS = Not statistically significant; LVDd = Left ventricular dimension in diastole; LVDs = Left ventricular dimension in systole; 
FS = Fractional shortening; EF = Ejection fraction; IVST = Interventricular septal thickness; PWT = Posterior wall thickness; RVD = Right ventricular 
dimension; AOD = Aortic root dimension; ACS = Aortic cusp separation; LAD = Left atrial dimension; LV = Left ventricular
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The blood pressure response to exercise was significantly 
higher in hypertensives with LVH than hypertensive and 
normotensive controls in agreement with other studies.[20]
The peak exercise diastolic blood pressure compared with 
rest values, was expectedly reduced in normal controls, 
a finding consistent with earlier studies.[17] This tends to 
support the observation that hypertensives maintain a 
higher total peripheral resistance at all levels of exercise as 
shown from invasive measurement[21] than normal subjects.
The parameters of systolic function e.g. fractional shortening, 
ejection fraction were comparable among hypertensives 
with LVH and normotensive controls. This is in agreement 
with previous studies.[6,22] Ajayi and Akinwusi[6] had found 
comparable left ventricular contractility indices among 
normotensive and mildly hypertensive Nigerians. Similarly 
Lawal et al.[22] had previously demonstrated that the ejection 
fraction, mean velocity of circumferential shortening and 
fractional shortening in mild hypertensive Nigerians are 
similar to those of the normotensives. 
This study showed that ejection fraction, fractional 
shortening, isovolumic relaxation time and Doppler 
transmitral flow velocity pattern correlate with metabolic 
equivalent in hypertensives with LVH. These results are 
in agreement with that of Ajayi et al.[6] who reported 
correlation between systolic parameters and indices of 
exercise capacity among heart failure patients during 
treadmill exercise testing.
However, several other studies have shown that measures 
of left ventricular systolic function are poor predictors of 
exercise capacity.[23] Lewis et al.[24] reported that exercise 
capacity after myocardial infarction did not correlate with 
left ventricular systolic function but did with diastolic 
function. In their study exercise capacity was inversely 
related to transmitral A velocity and directly to the E/A.
Echocardiographic Doppler indices of left ventricular 
diastolic function have been reported to be related to 
exercise capacity in patients with LV systolic function.[25]      
In this study, exercise capacity was directly related 
to the mitral E/A ratio. Since the introduction of the 
Doppler transmitral flow pattern analysis, non-invasive 
routine assessment of left ventricular diastolic function 
has become available.[26] Some workers have reported 
on the association of left ventricular diastolic function 
and exercise capacity in normal individuals. [27,28] 
Vanoverschelde et al.[27] studied 66 healthy individuals 
and found that the mitral E/A ratio was the strongest 
independent predictor of exercise capacity. Genovesi-
Ebert et al.[28] studied 20 healthy individuals and 
34 patients with hypertension and showed that 
Echocardiographic Doppler indices of left ventricular 
filling were associated with exercise capacity.
Several previous authors have reported some possible 
reasons for the impaired exercise capacity associated with 
diastolic dysfunction.
Coucolo et al.[29] studied patients with essential hypertension 
and LVH and reported that an abnormal LVEF response 
during exercise in patients with impaired early diastolic 
filling was related to their decreased exercise capacity. They 
found a significant correlation between left ventricular 
mass and diastolic indices in patients with hypertension. 
However, Vanoverschelde et al.[27] and this study showed 
no significant correlation between LV mass  and exercise 
capacity in hypertensives and normotensive controls.
Thus, it is supposed that the presence of diastolic 
dysfunction with or without increased left ventricular 
mass may limit LV stroke volume to increase despite the 
elevated left ventricular filling pressure during exercise. 
In addition, compensatory tachycardia to increase 
cardiac output would cause a further deterioration in left 
ventricular filling.
Conclusion
The results demonstrated significant impairment of exercise 
Table 5 : Multiple regression analysis of ECHO 






IVRT -0.336 0.014 (S)
LVDs 0.359 0.123 (NS)
FS -0.661 0.396 (NS)
EF 0.532 0.483 (NS)
Mitral E velocity 0.342 0.044 (S)
Mitral E/A ratio -0.170 0.340 (NS)
S = Statistically significant; NS = Not statistically significant
Table 4: Univariate analysis of ECHO parameters that 




IVRT vs Met -0.42 0.002 (S)
LVDs vs Met 0.41 0.003 (S)
Mitral E velocity 0.39 0.004 (S)
FS vs Met -0.38 0.006 (S)
EF vs Met -0.34 0.017 (S)
Mitral E/A ratio vs Met 0.30 0.033 (S)
LVDd vs Met 0.15 0.272 (NS)
LVM index vs Met 0.05 0.691 (NS)
S = Statistically significant; NS = Not statistically significant; 
MET = Metabolic equivalent
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capacity in hypertensives with or without LVH compared to 
normotensive subjects. The hypertensive with LVH patients 
showed worse cardiovascular responses to exercise when 
compared to hypertensives without LVH.
Finally the study showed that ejection fraction, fractional 
shortening and Doppler transmitral flow velocity patterns 
correlate with treadmill exercise capacity in hypertensives 
with LVH.
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